Overall Technical outlook

Price Summary

Regeneron Pharmaceuticals, Inc.'s stock opened at 769.17 on 2026-03-11, surged to a high of 783.12, hit a low of 765.0, and closed up 0.71% at 774.66, with 405200 shares traded.
In the last 52 weeks, the stock's top price was 812.27 and the bottom price was 483.07.
According to 27 analysts, the future price is anticipated to vary between 730.0 and 1057.0, with an average expected price of around 872.6667.

Technicals

Support and Resistance: The current price for REGN is 774.66, supported at 763.23 with resistance at 784.61. This indicates a trading range where 763.23 might prevent further declines, while 784.61 could hinder additional gains.
REGN supportResistance b4094d
Support/Resistance for REGN


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
REGN aroon b4094d
Aroon chart for Regeneron Pharmaceuticals, Inc.


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
REGN bbands b4094d
Bolinger Bands chart for Regeneron Pharmaceuticals, Inc.


Parabolic SAR: The PSAR remains bullish, setting a critical support level that may help sustain the market's upward trend. This persistent bullish outlook suggests that the market is likely to continue climbing, with the support level offering a foundation for further growth.
REGN psar b4094d
Parabolic Stop and Reverse chart for Regeneron Pharmaceuticals, Inc.


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
REGN stoch b4094d
Stochastic chart for Regeneron Pharmaceuticals, Inc.


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
REGN trippleSMA b4094d
Tripple SMA chart for Regeneron Pharmaceuticals, Inc.


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.